MedTrace Logo

Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy

NCT00424320 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether sodium bicarbonate is effective in the prevention of sodium-induced nephropathy

Conditions

  • Acute Kidney Failure

Interventions

DRUG

Sodium bicarbonate

Sponsors & Collaborators

  • Instituto Nacional de Cardiologia Ignacio Chavez

    lead OTHER

Principal Investigators

  • Emma Miranda Malpica, PhD · Ignacio Chávez National Institute of Cardiology

  • Marco A Martínez Ríos, MD, FACC · Ignacio Chávez National Institute of Cardiology

  • Jorge Gaspar Hernández, MD · Ignacio Chávez National Institute of Cardiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2007-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00424320 on ClinicalTrials.gov